Long-term CD4+ T-cell response in HIV-1-infected patients continuing combination antiretroviral therapy despite high-level viremia and drug resistance.
Dionisio
D
D
Infectious Diseases Unit, Pistoia Hospital, Piazza Giovanni XXIII, 51100 Pistoia, Italy. mpdioni@tin.it
Vivarelli
A
A
Zazzi
M
M
Esperti
F
F
Fabbri
C
C
Giorgi
M
M
Menichini
B
B
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D004334:Drug Administration Schedule; D024882:Drug Resistance, Viral; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012367:RNA, Viral / Q000032:analysis* / Q000187:drug effects; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014766:Viremia / Q000188:drug therapy* / Q000276:immunology*
D012367:RNA, Viral